4//SEC Filing
Nichols William Garrett 4
Accession 0000950170-25-100320
CIK 0001841387other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:30 PM ET
Size
8.7 KB
Accession
0000950170-25-100320
Insider Transaction Report
Form 4
Nichols Garrett
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-07-28$1.29/sh+937$1,209→ 53,430 total - Sale
Common Stock
2025-07-28$6.98/sh−937$6,540→ 52,493 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-07-28−937→ 29,377 totalExercise: $1.29Exp: 2033-04-28→ Common Stock (937 underlying)
Footnotes (2)
- [F1]This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024.
- [F2]This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date.
Documents
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0001618364
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 4:30 PM ET
- Size
- 8.7 KB